Dove Men+Care Encourages Canadian Dads to Celebrate ‘My Most Important Role' on LinkedIn
As part of the campaign, Canadian Dads are encouraged to use LinkedIn's 'Add position' feature to reflect their role as a father and join a growing movement of men reshaping the traditional definition of masculinity, identity, and care. Making fatherhood LinkedIn-official, Dove Men+Care sparks a broader conversation that urges men to treat personal milestones with the same importance and visibility as professional ones.
'Too often, men proudly share promotions, but rarely the presence and care they bring at home,' said Divya Singh, General Manager, Personal Care, Unilever Canada. 'With this campaign, we are redefining success to include care and celebrate the powerful role fathers and father figures play beyond the workplace.'
To kickstart the movement, Dove Men+Care partnered with Founder/CEO Ross Simmonds, Sports Commentator Donnovan Bennett, Celebrity Chef and TV host Dave Rocco, Innovation Strategist Shawn Kanungo. Each thought leader, known in Canada for their professional achievements, are sharing their personal fatherhood stories alongside custom visuals designed by Toronto-based illustrator Mateusz Napieralski. Canadians are encouraged to download and re-share these custom illustrations along with their own fatherhood update and journey.
"When men see fatherhood as a vital part of who they are, it positively shapes their mental health and emotional well-being," said Dr. Andrew Howlett, a Toronto-based Child and Family Psychiatrist, and co-founder of the Fathers' Mental Health Network. "By valuing and supporting active fatherhood, we help dads feel recognized and empowered - building resilient families and healthier communities."
As a long-time partner of Dove Men+Care, Dad Central, a national organization that provides research, programming, resources, and a community to support father involvement, is helping amplify the campaign through its extensive community network. The group is also contributing expert insight on the cultural importance of active fatherhood and its long-term impact on society.
The campaign runs nationally in the lead-up to Father's Day, encouraging Dads across Canada to take part on LinkedIn. To learn more about Dove Men+Care, visit dove.com/men-care. To find out more about Dad Central visit: https://dadcentral.ca.
About Dove Men+Care
Dove Men+Care is the first range of products from Dove developed specially for men. Manufactured by Unilever, the line includes the #1 dermatologist recommended male bar and body wash brand. Launched in 2010, the Dove Men+Care portfolio includes bars, body washes, anti-perspirant/deodorants, and hair care. Dove Men+Care is available nationwide in food, drug, and mass outlet stores.
About Unilever
Unilever is one of the world's leading suppliers of Beauty & Wellbeing, Personal Care, Home Care, Foods and Ice Cream products, with sales in over 190 countries and products used by 3.4 billion people every day. We have 128,000 employees and generated sales of €60.8 billion in 2024.
For more information about Unilever and our brands, please visit www.unilever.com.
About Unilever in North America
Unilever is one of the world's leading suppliers of Beauty & Wellbeing, Personal Care, Home Care, Foods and Ice Cream products, with sales in over 190 countries and products used by 3.4 billion people every day. We have 128,000 employees and generated sales of €60.8 billion in 2024.
Our leading brands in North America include Dove, Hellmann's, Vaseline, Degree, Axe, TRESemmé, Knorr, Magnum, Ben & Jerry's, Nutrafol, Liquid I.V., Paula's Choice, and Dermalogica.
For more information on Unilever U.S. and its brands visit: www.unileverusa.com
For more information on Unilever Canada and its brands visit: www.unilever.ca
About Unilever in Canada
Unilever is one of the world's leading suppliers of Beauty & Wellbeing, Personal Care, Home Care, Foods and Ice Cream products, with sales in over 190 countries and products used by 3.4 billion people every day. We have 128,000 employees and generated sales of €60.8 billion in 2024.
Our leading brands in Canada include Dove, Vaseline, Degree, Axe, SheaMoisture, TRESemmé, Knorr, Hellmann's, Breyers, Magnum, Ben & Jerry's, Liquid I.V., and OLLY.
For more information on Unilever Canada and visit: www.unilever.ca or www.unilever.ca/fr.
About Dad Central
Dad Central is a national non-profit organization dedicated to supporting and promoting responsible father involvement in Canada. Through evidence-based research, resources, and community programming, Dad Central helps fathers, families, and organizations recognize and strengthen the important role dads play in child development and family well-being. With over two decades of experience, Dad Central works to ensure every child has the opportunity to benefit from an involved and caring father.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time Business News
15 minutes ago
- Time Business News
Modern Dental Solutions in Windsor
Choosing the right dentist in Windsor means more than just getting a check-up—it's about finding someone who understands your unique dental goals. Whether you're interested in straighter teeth, a functional smile, or exploring your coverage options under the Canadian dental care plan, a trusted provider can guide the way. If crooked or crowded teeth are affecting your smile, Invisalign in Windsor might be the perfect solution. These clear aligners are nearly invisible and customized to gradually shift your teeth into place—without the discomfort or appearance of metal braces. Many adults and teens prefer Invisalign for its comfort and flexibility. Missing several teeth? High-quality dentures in Windsor can restore both function and confidence. Modern dentures are more comfortable and natural-looking than ever before. Whether you need partial or full dentures, your dentist will ensure a personalized fit that supports your lifestyle. The Canadian dental care plan offers financial relief for eligible patients, especially seniors and families. From preventive care to restorative solutions like dentures, this plan helps make essential treatments more affordable and accessible across Canada—including right here in Windsor. Typing 'dental clinic near me' brings up countless choices—but the key is choosing a clinic that blends technology, personalized care, and financial guidance under government-supported plans. From Invisalign consultations to denture fittings, finding the right partner in your oral health journey matters. With options like Invisalign, dentures, and access to the Canadian dental care plan, visiting a reliable dentist in Windsor can help you achieve a smile that feels as good as it looks. Don't wait—book a visit at a dental clinic near you today and take the first step toward better oral health. TIME BUSINESS NEWS
Yahoo
an hour ago
- Yahoo
Northwest Healthcare Properties Real Estate Investment Trust Announces July 2025 Distribution
Toronto, Ontario--(Newsfile Corp. - July 15, 2025) - Northwest Healthcare Properties Real Estate Investment Trust (TSX: (the "REIT" or "Northwest"), a leading owner and operator of healthcare real estate infrastructure in North America, Brazil, Europe and Australasia, announced today that the Trustees of the REIT have declared a distribution of $0.03 per unit for the month of July 2025, representing $0.36 per unit on an annualized basis. The distribution will be payable on August 15, 2025, to unitholders of record as at July 31, 2025. Northwest offers a distribution reinvestment plan (the "DRIP"). On each distribution date, eligible unitholders registered in the DRIP will have their cash distributions reinvested to purchase Trust Units and will also receive bonus Trust Units equal to 3% of their cash distributions. Complete details of the DRIP are available on the REIT's website at About Northwest Northwest provides investors with access to a portfolio of high-quality international healthcare real estate infrastructure comprised as at May 14, 2025, of interests in a diversified portfolio of 169 income-producing properties and 15.8 million square feet of gross leasable area located throughout major markets in North America, Brazil, Europe, and Australasia. The REIT's portfolio of medical outpatient buildings, clinics, and hospitals is characterized by long-term indexed leases and stable occupancies. Northwest leverages its global workforce in eight countries to serve as a long-term real estate partner to leading healthcare operators. For additional information please visit: Contacts: Zach Vaughan, CEO, Stephanie Karamarkovic, CFO, Alyssa Barry, Investor Relations, investors@ (416) 366-2000 Ext. 2202 To view the source version of this press release, please visit Sign in to access your portfolio
Business Wire
2 hours ago
- Business Wire
WELL Health Subsidiary WELLSTAR Provides Corporate Update Reflecting Improved Guidance and a Strong Acquisition Pipeline
VANCOUVER, British Columbia & TORONTO--(BUSINESS WIRE)--WELL Health Technologies Corp. (TSX: WELL) (' WELL ' or the ' Company '), a company focused on positively impacting health outcomes by leveraging technology to empower healthcare providers and their patients, is pleased to provide a corporate update highlighting continued momentum across its majority-owned subsidiary, WELLSTAR Technologies Corp. (' WELLSTAR '). WELLSTAR is tracking ahead of internal expectations, supported by robust organic growth, a strong acquisition pipeline, and accelerating adoption of its Nexus AI solution. WELLSTAR continues to demonstrate strong growth and execution, fueled by accelerating demand for its digital health solutions and steady progress across its platform. The business is tracking ahead of internal expectations and has updated its guidance for fiscal 2025 to over $74 million (1) in revenue and $22 million (1) in Adjusted EBITDA (2). WELLSTAR is also expected to end the year with total annual recurring revenue (ARR) of approximately $62 million and an exit ARR (3) of approximately $80 million, supported by robust organic expansion, continued adoption of its AI-powered tools, and inclusive of completing three acquisitions that are currently in signed LOI stage. Amir Javidan, CEO of WELLSTAR commented, 'We've had an excellent first half to 2025 as both our organic and inorganic growth engines are levelling up and are poised to deliver an outstanding, breakout performance for WELLSTAR in 2025. At the beginning of the year, we set an ambitious goal of reaching $100M in revenues on a run-rate basis in the next couple of years and based on the latest forecasts, we believe we may be approaching that goal a few quarters earlier than previously anticipated. Our current goal for year-end exit ARR for fiscal 2025 is $80 million which would represent a 50% increase over last year's exit ARR figure. Darren Hoegler, CFO of WELLSTAR commented, 'This upward revision reflects stronger-than-expected traction across WELLSTAR's core product suite as well as strong execution in the company's capital allocation program. We currently have three signed LOIs with targets that all deliver high-margin SaaS solutions and would be highly accretive to our business. I'm also pleased to report that the two acquisitions that were completed in Q4 2024 are both operating well and tracking in alignment with or ahead of our plan. Our objective is to ensure disciplined execution and that the company continues to be positioned as a category leader in Canadian digital health, delivering durable, capital-efficient growth with significant operating leverage over time.' Three LOIs Executed as WELLSTAR Executes on Deep Acquisition Pipeline WELLSTAR has executed three letters of intent (LOIs) for acquisitions that are expected to contribute approximately $15 million in ARR, $16 million in revenue, and over $5 million in Adjusted EBITDA on an annualized run-rate basis. These prospective additions reflect WELLSTAR's continued focus on disciplined, accretive growth through the acquisition of complementary digital health assets that strengthen its core platform and expand its national footprint. The acquisitions are aligned with WELLSTAR's long-term strategy to build a technology-enabled healthcare infrastructure that is efficient, scalable, and outcomes-driven. Each target adds strategic value by extending WELLSTAR's clinician enablement capabilities. The integrated nature of WELLSTAR's platform enables smooth onboarding and operational alignment, allowing new assets to benefit from shared infrastructure and drive incremental impact across the broader business. WELLSTAR continues to advance a deep and well-qualified acquisition pipeline, with additional opportunities under review. Strong Early Traction for Nexus AI with Clinicians Nationwide Since its launch on May 7, 2025, Nexus AI has seen strong adoption, with over 2,400 providers signed up across primary care clinics, hospitals, and regional health authorities. Nexus AI's first feature, an ambient medical scribe for real-time clinical documentation, is already demonstrating meaningful value for providers by reducing administrative burden and cognitive load. AI medical scribe technology has been shown to save providers up to two hours per day in charting and documentation (4). Nexus AI serves as the central platform for WELLSTAR's expanding suite of AI-powered capabilities, including disease detection, medical coding and billing automation, and clinical decision support. Its compatibility with Canada's leading EMRs positions it as a scalable infrastructure layer for modern, intelligent healthcare delivery. Clinician engagement with Nexus AI is expected to contribute to WELLSTAR's recurring SaaS revenue and margin profile as deployments scale. Just as importantly, the platform's ability to orchestrate complex clinical workflows in an intuitive and context-aware way supports broader system-level efficiency and provider satisfaction. As a pre-qualified vendor of the Canada Health Infoway AI Scribe Program, eligible primary care clinicians across Canada will receive a fully-funded license for 12 months of Nexus AI. WELLSTAR recognizes this as a transformative opportunity to advance Canada's vision of connected care, where AI-enabled technologies reduce physician burnout, improve patient experience, and allow providers to focus more on engagement and less on documentation. By delivering accurate, secure documentation at the point of care, Nexus AI empowers providers to reclaim meaningful patient connections and supports a broader effort to integrate AI technologies that promote more connected, patient-centred care. Footnotes: WELLSTAR's guidance of $74 million in revenue and $22 million in Adjusted EBITDA in fiscal 2025 includes the impact from the three LOIs noted herein which will contribute approximately $4 million in revenue and $1 million in Adjusted EBITDA for inclusion in fiscal 2025. Note that this figure does not include certain shared services that are provided by WELL Health to WELLSTAR. Adjusted EBITDA is a non-GAAP financial measure. Please refer to WELL's most recent Management's Discussion and Analysis (MD&A), available under the Company's profile on SEDAR+ at for further details including definitions and reconciliations to the nearest IFRS measure. Exit ARR or Annual Recurring Revenue is based on the Company's revenue run-rate or ARR as annualized based on the last quarter of the year. The projected Exit ARR of approximately $80 million includes contribution from the three LOIs noted herein. Source: OntarioMD, AI scribes show promising results in helping family doctors and nurse practitioners spend more time with patients and less time on paperwork, September 11, 2024. WELL HEALTH TECHNOLOGIES CORP. Per: 'Hamed Shahbazi' Chief Executive Officer, Chairman and Director WELL Health Technologies Inc. WELL's mission is to tech-enable healthcare providers. We do this by developing the best technologies, services, and support available, which ensures healthcare providers are empowered to positively impact patient outcomes. WELL's comprehensive healthcare and digital platform includes extensive front and back-office management software applications that help physicians run and secure their practices. WELL's solutions enable more than 42,000 healthcare providers between the US and Canada and power the largest owned and operated healthcare ecosystem in Canada with more than 210 clinics supporting primary care, specialized care, and diagnostic services. In the United States, WELL's solutions are focused on specialized markets such as the gastrointestinal market, women's health, primary care, and mental health. WELL is publicly traded on the Toronto Stock Exchange under the symbol 'WELL' and on the OTC Exchange under the symbol 'WHTCF'. To learn more about the Company, please visit: Forward-Looking Statements Certain statements in this press release, constitute 'forward-looking information' and 'forward looking statements' (collectively, 'forward looking statements') within the meaning of applicable Canadian securities laws, including the guidance related to revenue and adjusted EBITDA, and the expected pipeline of future acquisition targets (and the associated run-rate revenue). Forward-looking statements are necessarily based upon management's expectations, while considered reasonable by WELL as of the date of such statements, are outside of WELL's control and are inherently subject to business, economic and other uncertainties and contingencies which could result in the forward-looking statements ultimately being entirely or partially incorrect or untrue. Forward looking statements contained in this press release are based on various assumptions, including, but not limited to the ability to continue to offer its products and services, complete the acquisitions, and the acquisition companies having the expected revenue and Adjusted EBITDA profiles based on WELL's diligence. Known and unknown risk factors, many of which are beyond the control of WELL could cause the actual plans to differ materially from the results implied by such forward-looking statements. Such risk factors include losing customers to competitors, cybersecurity threats which prevent WELLSTAR from being able to continually offer its products, not completing the three acquisitions discussed above, and the other risks discussed under the section entitled 'Risk Factors' in WELL's most recent annual information form, which is available under the Company's respective SEDAR+ profile at which could affect WELL's and WELLSTAR's business. The risk factors are not intended to represent a complete list of the factors that could affect WELL or WELLSTAR and the reader is cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking statements. There can be no assurance that forward looking statements will prove to be accurate. Forward-looking statements are provided for the purpose of providing information about management's expectations and plans relating to the future. WELL disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, or to explain any material difference between subsequent actual events and such forward-looking statements, except to the extent required by applicable law. All of the forward-looking statements contained in this press release are qualified by these cautionary statements.
